SEC Form 4 · accession 0001179110-15-009348
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nesli Basgoz
Director
Period of report
Jun 4, 2015
Accepted (ET)
Jun 8, 2015 · 5:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001 | Jun 4, 2015 | F | 334 | $303.38 | D | 3,460 | D | |
| Ordinary Shares, par value $0.0001F1,F2 | Jun 5, 2015 | A | 826 | $302.30 | A | 4,286 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares of restricted stock shall vest 100% on the earlier of (i) the day before the 2016 Annual Shareholder Meeting or (ii) June 4, 2016.
- F2Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Actavis plc.